Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a major health problem worldwide and most cases are incurable because of late presentation. It is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulation. Portal vein thrombosis (PVT) is a com...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2018/7568742 |
id |
doaj-ed17eef9d7344e11983b7af55ef344f9 |
---|---|
record_format |
Article |
spelling |
doaj-ed17eef9d7344e11983b7af55ef344f92020-11-24T21:52:09ZengHindawi LimitedCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972018-01-01201810.1155/2018/75687427568742Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular CarcinomaPeyda Korhan0Yeliz Yılmaz1Ezgi Bağırsakçı2Ayşim Güneş3Hande Topel4Brian I. Carr5Neşe Atabey6Izmir Biomedicine and Genome Center, 35340, TurkeyIzmir Biomedicine and Genome Center, 35340, TurkeyIzmir Biomedicine and Genome Center, 35340, TurkeyIzmir Biomedicine and Genome Center, 35340, TurkeyIzmir Biomedicine and Genome Center, 35340, TurkeyIzmir Biomedicine and Genome Center, 35340, TurkeyIzmir Biomedicine and Genome Center, 35340, TurkeyHepatocellular carcinoma (HCC) is a major health problem worldwide and most cases are incurable because of late presentation. It is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulation. Portal vein thrombosis (PVT) is a common complication of HCC that is associated with a poor prognosis. Heparin derivatives are widely used in the management of venous thromboembolism (VTE). Among them low molecular weight heparin (LMWH) favorably influences the survival in patients with advanced cancer, including HCC. Due to their pleiotropic function, heparins affect tumorigenesis in many ways and may promote or hamper tumorigenic transformation depending on the cancer type and cancer stage along with their structural properties and concentration. Thus, their application as an antithrombotic along with the conventional therapy regime should be carefully planned to develop the best management strategies. In this review, we first will briefly review clinical applications of heparin derivatives in the management of cancer with a particular focus on HCC. We then summarize the state of knowledge whereby heparin can crosstalk with molecules playing a role in hepatocarcinogenesis. Lastly, we highlight new experimental and clinical research conducted with the aim of moving towards personalized therapy in cancer patients at risk of thromboembolism.http://dx.doi.org/10.1155/2018/7568742 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Peyda Korhan Yeliz Yılmaz Ezgi Bağırsakçı Ayşim Güneş Hande Topel Brian I. Carr Neşe Atabey |
spellingShingle |
Peyda Korhan Yeliz Yılmaz Ezgi Bağırsakçı Ayşim Güneş Hande Topel Brian I. Carr Neşe Atabey Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma Canadian Journal of Gastroenterology and Hepatology |
author_facet |
Peyda Korhan Yeliz Yılmaz Ezgi Bağırsakçı Ayşim Güneş Hande Topel Brian I. Carr Neşe Atabey |
author_sort |
Peyda Korhan |
title |
Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma |
title_short |
Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma |
title_full |
Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma |
title_fullStr |
Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma |
title_full_unstemmed |
Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma |
title_sort |
pleiotropic effects of heparins: from clinical applications to molecular mechanisms in hepatocellular carcinoma |
publisher |
Hindawi Limited |
series |
Canadian Journal of Gastroenterology and Hepatology |
issn |
2291-2789 2291-2797 |
publishDate |
2018-01-01 |
description |
Hepatocellular carcinoma (HCC) is a major health problem worldwide and most cases are incurable because of late presentation. It is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulation. Portal vein thrombosis (PVT) is a common complication of HCC that is associated with a poor prognosis. Heparin derivatives are widely used in the management of venous thromboembolism (VTE). Among them low molecular weight heparin (LMWH) favorably influences the survival in patients with advanced cancer, including HCC. Due to their pleiotropic function, heparins affect tumorigenesis in many ways and may promote or hamper tumorigenic transformation depending on the cancer type and cancer stage along with their structural properties and concentration. Thus, their application as an antithrombotic along with the conventional therapy regime should be carefully planned to develop the best management strategies. In this review, we first will briefly review clinical applications of heparin derivatives in the management of cancer with a particular focus on HCC. We then summarize the state of knowledge whereby heparin can crosstalk with molecules playing a role in hepatocarcinogenesis. Lastly, we highlight new experimental and clinical research conducted with the aim of moving towards personalized therapy in cancer patients at risk of thromboembolism. |
url |
http://dx.doi.org/10.1155/2018/7568742 |
work_keys_str_mv |
AT peydakorhan pleiotropiceffectsofheparinsfromclinicalapplicationstomolecularmechanismsinhepatocellularcarcinoma AT yelizyılmaz pleiotropiceffectsofheparinsfromclinicalapplicationstomolecularmechanismsinhepatocellularcarcinoma AT ezgibagırsakcı pleiotropiceffectsofheparinsfromclinicalapplicationstomolecularmechanismsinhepatocellularcarcinoma AT aysimgunes pleiotropiceffectsofheparinsfromclinicalapplicationstomolecularmechanismsinhepatocellularcarcinoma AT handetopel pleiotropiceffectsofheparinsfromclinicalapplicationstomolecularmechanismsinhepatocellularcarcinoma AT brianicarr pleiotropiceffectsofheparinsfromclinicalapplicationstomolecularmechanismsinhepatocellularcarcinoma AT neseatabey pleiotropiceffectsofheparinsfromclinicalapplicationstomolecularmechanismsinhepatocellularcarcinoma |
_version_ |
1725876587293835264 |